CMRX logo

Chimerix (CMRX) EBITDA

Annual EBITDA

-$92.97 M
-$32.69 M-54.22%

December 31, 2023


Summary


Performance

CMRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMRXprofitabilitymetrics:

Quarterly EBITDA

-$24.77 M
-$1.96 M-8.61%

September 30, 2024


Summary


Performance

CMRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMRXprofitabilitymetrics:

TTM EBITDA

-$92.73 M
+$1.89 M+2.00%

September 30, 2024


Summary


Performance

CMRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMRXprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CMRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-54.2%-1.7%+0.4%
3 y3 years-110.8%-16.2%-60.9%
5 y5 years-31.4%-16.2%-60.9%

CMRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-54.2%at low-312.3%+37.3%-60.9%+12.7%
5 y5-year-110.8%at low-312.3%+37.3%-171.8%+12.7%
alltimeall time-3614.5%+20.9%-312.3%+37.3%-6006.7%+23.8%

Chimerix EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$24.77 M(+8.6%)
-$92.73 M(-2.0%)
Jun 2024
-
-$22.81 M(-6.4%)
-$94.63 M(+1.6%)
Mar 2024
-
-$24.37 M(+17.2%)
-$93.15 M(+0.2%)
Dec 2023
-$92.97 M(+54.2%)
-$20.79 M(-22.0%)
-$92.97 M(-3.1%)
Sep 2023
-
-$26.67 M(+25.0%)
-$95.98 M(+66.5%)
Jun 2023
-
-$21.32 M(-11.9%)
-$57.64 M(-3.5%)
Mar 2023
-
-$24.20 M(+1.7%)
-$59.74 M(-0.9%)
Dec 2022
-$60.29 M(-33.3%)
-$23.79 M(-303.8%)
-$60.29 M(-20.7%)
Sep 2022
-
$11.67 M(-149.8%)
-$76.01 M(-28.5%)
Jun 2022
-
-$23.42 M(-5.4%)
-$106.24 M(+5.6%)
Mar 2022
-
-$24.75 M(-37.4%)
-$100.60 M(+11.4%)
Dec 2021
-$90.34 M(+104.8%)
-$39.51 M(+112.8%)
-$90.34 M(+44.6%)
Sep 2021
-
-$18.56 M(+4.4%)
-$62.50 M(+12.8%)
Jun 2021
-
-$17.78 M(+22.7%)
-$55.40 M(+15.9%)
Mar 2021
-
-$14.49 M(+24.2%)
-$47.80 M(+8.4%)
Dec 2020
-$44.11 M(-12.4%)
-$11.66 M(+1.7%)
-$44.11 M(+21.8%)
Sep 2020
-
-$11.47 M(+12.6%)
-$36.21 M(+6.1%)
Jun 2020
-
-$10.18 M(-5.7%)
-$34.12 M(-19.7%)
Mar 2020
-
-$10.80 M(+187.3%)
-$42.48 M(-15.7%)
Dec 2019
-$50.37 M(-28.8%)
-$3.76 M(-59.9%)
-$50.37 M(-18.6%)
Sep 2019
-
-$9.37 M(-49.4%)
-$61.86 M(-10.3%)
Jun 2019
-
-$18.54 M(-0.8%)
-$69.00 M(-0.6%)
Mar 2019
-
-$18.70 M(+22.6%)
-$69.38 M(-1.9%)
Dec 2018
-$70.75 M
-$15.25 M(-7.6%)
-$70.75 M(-4.3%)
Sep 2018
-
-$16.51 M(-12.8%)
-$73.92 M(-1.5%)
Jun 2018
-
-$18.93 M(-5.6%)
-$75.05 M(+2.7%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$20.06 M(+8.9%)
-$73.09 M(+2.9%)
Dec 2017
-$71.01 M(-7.6%)
-$18.42 M(+4.4%)
-$71.01 M(+4.9%)
Sep 2017
-
-$17.64 M(+4.0%)
-$67.68 M(+0.7%)
Jun 2017
-
-$16.97 M(-5.6%)
-$67.20 M(-1.9%)
Mar 2017
-
-$17.98 M(+19.1%)
-$68.50 M(-10.9%)
Dec 2016
-$76.89 M(-34.6%)
-$15.09 M(-12.1%)
-$76.89 M(-23.0%)
Sep 2016
-
-$17.16 M(-6.0%)
-$99.81 M(-13.4%)
Jun 2016
-
-$18.27 M(-30.7%)
-$115.21 M(-5.4%)
Mar 2016
-
-$26.36 M(-30.6%)
-$121.75 M(+3.5%)
Dec 2015
-$117.59 M(+100.7%)
-$38.01 M(+16.7%)
-$117.59 M(+17.9%)
Sep 2015
-
-$32.57 M(+31.3%)
-$99.71 M(+18.8%)
Jun 2015
-
-$24.80 M(+11.6%)
-$83.91 M(+18.8%)
Mar 2015
-
-$22.21 M(+10.4%)
-$70.66 M(+20.6%)
Dec 2014
-$58.58 M(+106.6%)
-$20.13 M(+20.0%)
-$58.58 M(+26.3%)
Sep 2014
-
-$16.77 M(+45.2%)
-$46.37 M(+28.9%)
Jun 2014
-
-$11.55 M(+14.0%)
-$35.98 M(+12.4%)
Mar 2014
-
-$10.13 M(+28.0%)
-$32.01 M(+12.9%)
Dec 2013
-$28.36 M(+1033.1%)
-$7.92 M(+24.2%)
-$28.36 M(+15.7%)
Sep 2013
-
-$6.37 M(-16.0%)
-$24.52 M(+260.5%)
Jun 2013
-
-$7.59 M(+17.1%)
-$6.80 M(+90.7%)
Mar 2013
-
-$6.48 M(+59.1%)
-$3.57 M(+42.5%)
Dec 2012
-$2.50 M(-89.9%)
-$4.07 M(-135.9%)
-$2.50 M(-259.4%)
Sep 2012
-
$11.34 M(-360.5%)
$1.57 M(-116.1%)
Jun 2012
-
-$4.35 M(-19.6%)
-$9.77 M(+80.4%)
Mar 2012
-
-$5.42 M
-$5.42 M
Dec 2011
-$24.72 M(-1.5%)
-
-
Dec 2010
-$25.09 M
-
-

FAQ

  • What is Chimerix annual EBITDA?
  • What is the all time high annual EBITDA for Chimerix?
  • What is Chimerix annual EBITDA year-on-year change?
  • What is Chimerix quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Chimerix?
  • What is Chimerix quarterly EBITDA year-on-year change?
  • What is Chimerix TTM EBITDA?
  • What is the all time high TTM EBITDA for Chimerix?
  • What is Chimerix TTM EBITDA year-on-year change?

What is Chimerix annual EBITDA?

The current annual EBITDA of CMRX is -$92.97 M

What is the all time high annual EBITDA for Chimerix?

Chimerix all-time high annual EBITDA is -$2.50 M

What is Chimerix annual EBITDA year-on-year change?

Over the past year, CMRX annual EBITDA has changed by -$32.69 M (-54.22%)

What is Chimerix quarterly EBITDA?

The current quarterly EBITDA of CMRX is -$24.77 M

What is the all time high quarterly EBITDA for Chimerix?

Chimerix all-time high quarterly EBITDA is $11.67 M

What is Chimerix quarterly EBITDA year-on-year change?

Over the past year, CMRX quarterly EBITDA has changed by -$404.00 K (-1.66%)

What is Chimerix TTM EBITDA?

The current TTM EBITDA of CMRX is -$92.73 M

What is the all time high TTM EBITDA for Chimerix?

Chimerix all-time high TTM EBITDA is $1.57 M

What is Chimerix TTM EBITDA year-on-year change?

Over the past year, CMRX TTM EBITDA has changed by +$411.00 K (+0.44%)